Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

GENIE: A Two-Stage Interpretable Deep Learning Framework for Revealing the High-Order Genetic Interaction Network of Alzheimer's Disease.

IEEE transactions on computational biology and bioinformatics·2026

Same author

Divergent structure but convergent metabolic organization of tetrabromobisphenol A degrading microbial consortia from aerobic and anaerobic conditions.

Journal of hazardous materials·2026

Same author

The pectate lyase OsPSE1 mediates root cell-wall pectin turnover to regulate senescence in rice.

Plant physiology and biochemistry : PPB·2026

Same author

Molecular confinement for enhanced interfacial contact and performance in inverted perovskite solar cells.

Nature communications·2026

Same author

A Novel Prognostic Signature Composed of Autophagy and Liver Metastasis in Colorectal Cancer: Comprehensive Analysis of Bulk and Single-Cell Transcriptomic Data.

ImmunoTargets and therapy·2026

Same author

Interleukin-6 as a Biomarker for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Study.

International journal of general medicine·2026

Same journal

OmicsTransformer: Self-Supervised Masked Consistency and Uncertainty-Aware Fusion for Robust Multi-Omics Prediction.

Bioinformatics (Oxford, England)·2026

Same journal

Computational Tool Choice Impacts CRISPR Spacer-Proto spacer Detection.

Bioinformatics (Oxford, England)·2026

Same journal

ARISE: RNA-Anchored Shared-Edge Topology and Hierarchical Fusion for Spatial Multi-Omics Integration.

Bioinformatics (Oxford, England)·2026

Same journal

Interactive exploration of biobank-scale ancestral recombination graphs with Lorax.

Bioinformatics (Oxford, England)·2026

Same journal

PepMCP: A Graph-Based Membrane Contact Probability Predictor for Membrane-Lytic Antimicrobial Peptides.

Bioinformatics (Oxford, England)·2026

Same journal

ARGscape: A modular, interactive tool for manipulation of spatiotemporal ancestral recombination graphs.

Bioinformatics (Oxford, England)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

EPIC: multi-objective guided diffusion for epitope design in TCR-pMHC complexes.

Yueshan Huang¹, Gufeng Yu¹, Letian Chen^1,2

¹AGI Institute, School of Computer Science, Shanghai Jiao Tong University, Shanghai 200240, China.

Bioinformatics (Oxford, England)

|June 4, 2026

Summary

This summary is machine-generated.

EPIC is a novel computational framework for designing novel epitopes that bind to T cell receptors (TCRs) and peptide-MHC (pMHC) complexes. This tool enables the creation of personalized cancer vaccines and therapies by optimizing antigenicity, MHC presentation, and TCR specificity.

More Related Videos

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells

Published on: October 22, 2012

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Related Experiment Videos

Last Updated: Jun 6, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells

Published on: October 22, 2012

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Area of Science:

Computational biology
Immunology
Bioinformatics

Background:

T cell receptor (TCR) recognition of peptide-MHC (pMHC) complexes is crucial for adaptive immunity.
Designing immunogenic epitopes is challenging due to complex binding constraints and limited data.
Existing methods cannot simultaneously ensure antigenicity, MHC presentation, and TCR specificity.

Purpose of the Study:

To develop a computational framework for the de novo design of epitopes.
To address the limitations of existing epitope design methods by integrating triplet binding constraints.
To enable the generation of epitopes with tailored immunological properties.

Main Methods:

EPIC utilizes a multi-objective diffusion framework.
It decomposes TCR-pMHC binding into three biologically grounded sub-tasks.
ESM-based classifiers and a peptide diffusion generator are integrated, leveraging diverse immunological datasets.

Main Results:

EPIC-designed epitopes show improved predicted interface energies compared to ground-truth epitopes.
Generated epitopes demonstrate high sequence novelty (80.1%), uniqueness (100%), and diversity (64.05%).
The framework achieves high antigenicity scores (0.4723) and comparable structural confidence.

Conclusions:

EPIC is the first computational framework for de novo epitope design integrating TCR-pMHC triplet constraints.
This approach facilitates the design of epitopes for personalized cancer vaccines and T cell therapies.
EPIC represents a paradigm shift from epitope discovery to rational epitope design.